The pathogenesis of heart failure with preserved ejection fraction (HFpEF) secondary to type 2 diabetes mellitus (T2DM) is complex, and the role of fibroblast activation protein (FAP) remains elusive. This evidence concerns the gene FAP and diabetes mellitus.